<qa>  What is the final eligibility for this study?- Patients with an expected survival period of 6 months or greater and who have been diagnosed with any stage of diffuse large B-cell lymphoma or Hodgkins disease will be eligible to participate in this study. Final eligibility will be determined by the health professionals conducting this trial. 